Apelin/APJ: Another Player in the Cancer Biology Network

Laura Naldi1,2, Alessandro Peri1,2, Benedetta Fibbi1,2

  • 1"Pituitary Diseases and Sodium Alterations" Unit, AOU Careggi, 50139 Florence, Italy.

Insights

The apelin/APJ system fuels cancer growth and spread by impacting key cancer hallmarks. Targeting this pathway may improve cancer treatments and diagnostics.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The apelinergic system, involving apelin and its receptor APJ, plays a role in human diseases, including cancer.
  • Overactivation of the apelin/APJ pathway is observed in many malignant tumors and correlates with patient survival.
  • The apelin gene is suggested to function as an oncogene due to its role in cancer progression.

Purpose of the Study:

  • To review the literature on intracellular processes regulated by the apelin/APJ pathway in cancer.
  • To focus on pathways linked to tumor development, progression, and hallmarks of cancer.
  • To explore the potential of the apelin/APJ axis as a therapeutic and diagnostic target in oncology.

Main Methods:

  • Literature review of existing studies on the apelinergic system in cancer.
  • Analysis of intracellular signaling pathways affected by apelin/APJ.
  • Examination of the association between apelin/APJ activity and cancer hallmarks.
  • Investigation of apelin/APJ's role in cancer treatment resistance.

Main Results:

  • Apelin/APJ signaling influences multiple cancer hallmarks, including proliferation, apoptosis resistance, invasion, metastasis, angiogenesis, metabolism, immune evasion, inflammation, and immortality.
  • The apelin/APJ axis is implicated in cancer cell resistance to chemotherapy, immunotherapy, and radiation.
  • Evidence suggests apelin/APJ contributes to tumor development and progression.

Conclusions:

  • The apelin/APJ pathway is a significant factor in cancer biology, affecting numerous hallmarks of cancer.
  • Targeting the apelin/APJ axis presents a promising strategy to enhance conventional cancer therapies.
  • The apelin/APJ system holds potential for developing novel diagnostic and prognostic tools in cancer care.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.5K